Latest news
Capricor seeks court intervention in fight over DMD cell therapy launch - FirstWord PHARMAFirstWord PHARMA · Wed, 05 Aug 2026 07:00:00 GMTFDA advisers reject evidence for Duchenne heart therapy - Muscular Dystrophy NewsMuscular Dystrophy News · Tue, 04 Aug 2026 17:04:06 GMTCapricor’s Duchenne AdCom Didn’t Fail on Science. It Failed on Statistics. - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 04 Aug 2026 07:38:27 GMTCapricor CEO won’t rule out legal action against FDA after negative adcomm - BioSpaceBioSpace · Fri, 31 Jul 2026 18:43:14 GMTFDA advisory panel votes against Capricor's Duchenne cell therapy deramiocel - app.dealroom.coapp.dealroom.co · Thu, 30 Jul 2026 22:39:44 GMTFDA Committee Vote Against Approving Capricor’s Deramiocel - Inside Precision MedicineInside Precision Medicine · Thu, 30 Jul 2026 16:46:11 GMTFDA AdCom shuns Capricor’s DMD cell therapy amid data dispute - Pharmaceutical TechnologyPharmaceutical Technology · Thu, 30 Jul 2026 14:06:52 GMTFDA advisors vote no to Capricor's DMD therapy - pharmaphorumpharmaphorum · Thu, 30 Jul 2026 09:10:40 GMT